999 related articles for article (PubMed ID: 30423561)
1. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
[TBL] [Abstract][Full Text] [Related]
2. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
Huang HL; Chen HT; Luo QL; Xu HM; He J; Li YQ; Zhou YL; Yao F; Nie YQ; Zhou YJ
J Dig Dis; 2019 Aug; 20(8):401-408. PubMed ID: 31070838
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study.
Holster S; Lindqvist CM; Repsilber D; Salonen A; de Vos WM; König J; Brummer RJ
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00034. PubMed ID: 31009405
[TBL] [Abstract][Full Text] [Related]
4. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
5. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
[TBL] [Abstract][Full Text] [Related]
6. Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan.
Hamazaki M; Sawada T; Yamamura T; Maeda K; Mizutani Y; Ishikawa E; Furune S; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Nakamura M; Fujishiro M
BMC Gastroenterol; 2022 Jul; 22(1):342. PubMed ID: 35836115
[TBL] [Abstract][Full Text] [Related]
7. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
[TBL] [Abstract][Full Text] [Related]
8. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
[TBL] [Abstract][Full Text] [Related]
9. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
[TBL] [Abstract][Full Text] [Related]
10. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
[TBL] [Abstract][Full Text] [Related]
11. Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms.
Browne PD; Cold F; Petersen AM; Halkjær SI; Christensen AH; Günther S; Hestbjerg Hansen L
Gut Microbes; 2021; 13(1):1-16. PubMed ID: 34074214
[TBL] [Abstract][Full Text] [Related]
12. Exploring the genetic diversity of the 16S rRNA gene of
Lo Presti A; Del Chierico F; Altomare A; Zorzi F; Cella E; Putignani L; Guarino MPL; Monteleone G; Cicala M; Angeletti S; Ciccozzi M
Future Microbiol; 2019 Nov; 14():1497-1509. PubMed ID: 31850811
[No Abstract] [Full Text] [Related]
13. Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies.
Körner E; Lorentz A
J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36882216
[TBL] [Abstract][Full Text] [Related]
14. Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome.
Goll R; Johnsen PH; Hjerde E; Diab J; Valle PC; Hilpusch F; Cavanagh JP
Gut Microbes; 2020 Nov; 12(1):1794263. PubMed ID: 32991818
[TBL] [Abstract][Full Text] [Related]
15. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome.
Lahtinen P; Jalanka J; Hartikainen A; Mattila E; Hillilä M; Punkkinen J; Koskenpato J; Anttila VJ; Tillonen J; Satokari R; Arkkila P
Aliment Pharmacol Ther; 2020 Jun; 51(12):1321-1331. PubMed ID: 32343000
[TBL] [Abstract][Full Text] [Related]
16. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
Chen J; Lan H; Li C; Xie Y; Cheng X; Xia R; Ke C; Liang X
J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38849305
[TBL] [Abstract][Full Text] [Related]
17. The microbiome of the oral mucosa in irritable bowel syndrome.
Fourie NH; Wang D; Abey SK; Sherwin LB; Joseph PV; Rahim-Williams B; Ferguson EG; Henderson WA
Gut Microbes; 2016 Jul; 7(4):286-301. PubMed ID: 26963804
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
El-Salhy M; Hatlebakk JG; Gilja OH; Bråthen Kristoffersen A; Hausken T
Gut; 2020 May; 69(5):859-867. PubMed ID: 31852769
[TBL] [Abstract][Full Text] [Related]
19. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
Lin H; Guo Q; Wen Z; Tan S; Chen J; Lin L; Chen P; He J; Wen J; Chen Y
Microb Cell Fact; 2021 Dec; 20(1):233. PubMed ID: 34963452
[TBL] [Abstract][Full Text] [Related]
20. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.
Kurokawa S; Kishimoto T; Mizuno S; Masaoka T; Naganuma M; Liang KC; Kitazawa M; Nakashima M; Shindo C; Suda W; Hattori M; Kanai T; Mimura M
J Affect Disord; 2018 Aug; 235():506-512. PubMed ID: 29684865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
